LONG-ACTING INJECTABLE ANTIPSYCHOTICS TREATMENT PATTERNS- A RAMQ DATABASE ANALYSIS

Author(s)

Lachaine J¹, Lapierre M¹, Abdalla N², Rouleau A³, Stip E⁴
¹University of Montreal, Montreal, QC, Canada, ²Lundbeck Canada Inc., Montreal, QC, Canada, ³Lundbeck SAS, Global Epidemiology, Issy-les-Moulineaux, France, ⁴, Montreal, QC, Canada

Presentation Documents

PMH82--strong-u-lachaine-j-u-sup-1-sup-strong-lapierre-m-sup-1-sup-abdalla-n-sup-2-sup-rouleau-a-sup-3-sup-stip-e-sup-4-sup-br-sup-1-sup-university-of-montreal-montreal-qc-canada-sup-2-sup-lundbeck-canada-inc-montreal-qc-canada-sup-3-sup-lu ...

OBJECTIVES: The objective of this study was to assess the treatment patterns of long-acting injectable antipsychotics (LAI-AP), notably in terms of treatment persistence and compliance, in a real life setting, using the provincial public drug reimbursement program database of the Régie de l’assurance maladie du Québec(RAMQ). METHODS: Patients with a diagnosis of schizophrenia/schizoaffective disorder, who were incident users (no use in the previous 12 months) of a LAI-AP prescribed between January 1^st

Conference/Value in Health Info

2014-05, ISPOR 2014, Palais des Congres de Montreal

Value in Health, Vol. 17, No. 3 (May 2014)

Code

PMH82

Topic

Health Service Delivery & Process of Care

Topic Subcategory

Prescribing Behavior, Treatment Patterns and Guidelines

Disease

Mental Health

Presentation